- Home
- / Schrodinger
Schrodinger
Patents and Patent Applications
60
FY, 2019
Revenue
$137.9 K
FY, 2021
Market Capitalization
$1.6 B
2023-01-20
Schrodinger Summary
Company summary
- Overview
- Schrodinger is a provider of molecular simulations and enterprise software solutions and services. It offers a technology platform, which integrates physics-based molecular simulations and machine learning for drug development and materials applications. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories.
- Type
- Public
- Status
- Active
- Founded
- 1990
- HQ
- New York, NY, US | view all locations
- Website
- https://www.schrodinger.com/
- Cybersecurity rating
- ESG rating
Key people
Geoff Porges, Chief Financial Officer
Shane Brauner, Executive Vice President, Chief Information Officer
Karen Akinsanya, President of R&D, Therapeutics
Operating MetricsView all
Customers with >$100K in Annual Contract Value
131
7.4%
FY, 2019
Active Customers
1.3K
10.1%
FY, 2019
Customers with >$1M in Annual Contract Value
10
9.1%
FY, 2019
LocationsView all
13 locations detected
New York, NY HQ
United States
Bertelsmann Building, 1540 Broadway 24th Floor
Cambridge, MA
United States
1 Main St 11th Floor
Natick, MA
United States
12 Michigan Dr
Portland, OR
United States
One Main Place, 101 SW Main St #1300
San Diego, CA
United States
9171 Towne Centre Dr
Shanghai, Shanghai Shi
China
220, 2nd Floor, Building, 333 Qinjiang Rd, Xuhui Qu
Schrodinger Financials
Summary financials
- Revenue (Q3, 2022)
- $37.0M
- Gross profit (Q3, 2022)
- $17.2M
- Net income (Q3, 2022)
- ($39.9M)
- Cash (Q3, 2022)
- $102.8M
- EBIT (Q3, 2022)
- ($46.2M)
- Enterprise value
- $1.6B
